Mira PharmaceuticalsMIRA
13F holders, Q1 2025 (March 31)19holders −5
3new positions
8sold out
$0.98avg. 13F price*
At the end of Q1 2025, 19 institutions reported holding Mira Pharmaceuticals Inc. (MIRA) in their 13F filings, down 5 from Q4 2024. 3 opened new positions and 8 sold out. The largest holders were Cross Staff Investments Inc ($356K), Geode Capital Management, LLC ($133K) and Vanguard Group Inc. ($115K).
- Company
- Mira Pharmaceuticals Inc.
- CUSIP
- 60458C104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $54K |
| Exits | 8 | $325K |
All 13F filers, Q4 2024 → Q1 2025: 159,244 shares bought and 312,725 shares sold, net −153,481 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Cross Staff Investments Inc | 0.27% | Reduce -0.7% | 363,401 | $356K |
| Geode Capital Management, LLC | 0.00% | Add +10.9% | 135,418 | $133K |
| Vanguard Group Inc. | 0.00% | No change | 117,824 | $115K |
| Suncoast Equity Management | 0.01% | Add +356.1% | 103,289 | $101K |
| State Street Corp. | 0.00% | No change | 49,100 | $48K |
| J.W. Cole Advisors, Inc. | 0.00% | New | 40,000 | $39K |
| Commonwealth Equity Services, LLC | 0.00% | Add +69.5% | 25,547 | $25K |
| Two Sigma Investments, LP | 0.00% | Reduce -8.0% | 22,374 | $22K |
| First American Bank | 0.00% | No change | 20,000 | $20K |
| Praetorian Wealth Management, Inc. | 0.00% | No change | 17,500 | $17K |
| Jane Street Group, LLC | 0.00% | New | 14,772 | $14K |
| Northern Trust Corp. | 0.00% | Reduce -55.2% | 13,595 | $13K |
| Mariner, LLC | 0.00% | No change | 11,500 | $11K |
| Two Sigma Securities, LLC | 0.00% | Reduce -27.1% | 11,033 | $11K |
| Bank of America Corp. | 0.00% | Add +0.0% | 10,103 | $10K |
| Cary Street Partners Financial LLC | 0.00% | No change | 10,000 | $10K |
| Osaic Holdings, Inc. | 0.00% | No change | 2,000 | $2K |
| Steward Partners Investment Advisory, LLC | 0.00% | Reduce -73.0% | 1,000 | $980 |
| JPMorgan Chase & Co. | 0.00% | New | 16 | $16 |
"% of holder's portfolio" is MIRA's weight in each manager's 13F, not the share of Mira Pharmaceuticals Inc. the manager owns.